Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
May 6th, 2021
Tag: Clinical trial
APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
April 12th, 2021
Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines
March 2nd, 2021
APDN, Evvivax and GVS Receive Approval for Veterinary COVID-19 Clinical Trial
November 30th, 2020
Veterinary COVID-19 Vaccine Clinical Trial
September 16th, 2020
LineaRx Signs Agreement with TYME Technologies for Functional ICTC Assay Services in Pancreatic Cancer Trial
November 26th, 2019
Stony Brook Co. Claims Its Prostate Cancer Test Superior PSA
October 1st, 2019